Literature DB >> 14410953

Technique for the study of alternate metabolic pathways: epinephrine metabolism in man.

I J KOPIN.   

Abstract

A general method of determining the relative magnitudes of different pathways of formation of a urinary metabolite from a single precursor substance is described. The method requires the administration of the precursor and an intermediate labeled with different isotopes, and the determination of the ratio of the isotopes in the metabolites. A preliminary application to epinephrine metabolism in man is presented.

Entities:  

Keywords:  EPINEPHRINE/metabolism

Mesh：

Substances：

Year:  1960        PMID： 14410953     DOI： 10.1126/science.131.3410.1372

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


  7 in total

1.  THE EXCRETION OF 4-HYDROXY-3-METHOXY-MANDELIC ACID BY CHILDREN.

Authors:  T MCKENDRICK; R W EDWARDS
Journal:  Arch Dis Child       Date:  1965-08       Impact factor: 3.791

2.  The estimation of 4-hydroxy-3-methoxymandelic acid in urine.

Authors:  M SANDLER; C R RUTHVEN
Journal:  Biochem J       Date:  1961-07       Impact factor: 3.857

3.  Metabolism of 7-H3-epinephrine-d-bitartrate in normal young men.

Authors:  E H LABROSSE; J AXELROD; I J KOPIN; S S KETY
Journal:  J Clin Invest       Date:  1961-02       Impact factor: 14.808

Review 4.  Catecholamine-secreting tumours.

Authors:  M Sandler
Journal:  Proc R Soc Med       Date:  1967-08

5.  Splanchnic and renal elimination and release of catecholamines in cirrhosis. Evidence of enhanced sympathetic nervous activity in patients with decompensated cirrhosis.

Authors:  J H Henriksen; H Ring-Larsen; I L Kanstrup; N J Christensen
Journal:  Gut       Date:  1984-10       Impact factor: 23.059

6.  [Studies on the excretion of catecholamines and their degradation products in hypertension and pheochromocytoma].

Authors:  R Clotten; J Michaelis
Journal:  Klin Wochenschr       Date:  1966-10-15

7.  4-hydroxy-3-methoxymandelic acid (HMMA) excretion in retinoblastoma.

Authors:  P L Dias; A A Amarasiri
Journal:  Br J Ophthalmol       Date:  1978-08       Impact factor: 4.638
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.